Alistagen
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10 Park Ave, New York City, New York, 10...Phone Number
(212) 317-0100Website
www.caliwel.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Alistagen
Alistagen Corporation is a privately held biotechnology company founded in 2000. The company was established by CEO Bryan Glynson and President Alis Yeterian with the specific objective of developing noninvasive, therapeutic and preventive treatments for respiratory illnesses and infectious diseases that could be broadly applied to hospitals, nursing homes, residences and commercial structures which are susceptible to microbial infestation. Alistagen's mission is to globally market and/or license Caliwel BNA-based applications that reduce the spread of infectious disease and improve public health care.Explore more
Popular SearchesAlistagen CorpAlistagenSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alistagen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Alistagen recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Alistagen has new funding data
Check out if Alistagen is spiking on competitors!
Product Launch: Get notified when Alistagen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Alistagen has recently received funding, and reach out quickly before it becomes old news!
Click to see if Alistagen had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Alistagen
Alistagen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Alistagen
Compare insights from companies similar to Alistagen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alistagen
$5.3M
11-50
Private
-
2000
N/A
Company Profile Activity
Activity Insights
Alistagen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Alistagen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Alistagen.
Alistagen Tech Stack
A closer look at the technologies used by Alistagen
See more technologies
Alistagen News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alistagen
Sign Up For FreeTo access detailed company insights
Alistagen Corporation is a privately held biotechnology company founded in 2000. The company was established by CEO Bryan Glynson and President Alis Yeterian with the specific objective of developing noninvasive, therapeutic and preventive treatments for respiratory illnesses and infectious diseases that could be broadly applied to hospitals, nursi... Read More
